News from nuevolution A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 22, 2019, 02:47 ET Statement by the Board of Directors of Nuevolution in Relation to the Public Offer From Amgen

This statement is made by the Board of Directors[1] of Nuevolution AB (publ) (the "Company" or "Nuevolution") pursuant to Rule II.19 of the Nasdaq...


May 22, 2019, 01:19 ET Nuevolution AB (publ) Announces its Results for the First Quarter of 2019

Nuevolution AB (publ) announces its report for the first quarter of 2019. The report is available on the company's home page (www.nuevolution.com)....


Aug 22, 2018, 13:15 ET Nuevolution Discloses the Identity of its "Cytokine X" Program being Interleukin IL-17A and Initiates Promotion of its Small Molecule IL-17A Inhibitor Program Targeting Inflammatory Diseases

Today, Nuevolution AB (publ) announced the identity of its "Cytokine X" program being a lead discovery program targeting inhibition of Interleukin...


Jan 23, 2018, 05:26 ET Nuevolution Appoint Dr. Paul Scigalla as Chief Medical Officer on Consultancy Basis

Nuevolution AB (publ) (NUE.ST) today announced the appointment of professor Paul Scigalla MD, PhD as new advisor to support Nuevolution in the role...


Jan 04, 2018, 01:50 ET Nuevolution to Receive License Fee Payment of USD 750,000

Nuevolution AB (publ) (NUE.ST) today announced that Janssen Biotech, one of the Pharmaceutical Companies of Johnson & Johnson, has exercised its...


Nov 27, 2017, 05:26 ET Nuevolution to Present New Data on its BET BD1 Program Supporting Effect in Psoriasis/Atopic Dermatitis

Nuevolution AB (publ) (NUE.ST) today announced that Thomas Franch, Chief Scientific Officer, will be presenting new data on Nuevolution's selective...


Nov 06, 2017, 11:06 ET Nuevolution Appoints Johnny Stilou as Director of Investor Relations and Corporate Communication

Nuevolution AB (publ) (NUE.ST) today announced the appointment of Johnny Stilou as Director of Investor Relations & Corporate Communication. This is...


Sep 06, 2017, 03:35 ET Nuevolution AB (publ) Announces its Results for the Fourth Quarter and Full Year 2016/17

8.30 AM CEST / 6-Sep-2017 / Nuevolution (SEMM: NUE) Nuevolution AB (publ) announces its report for the fourth quarter and full year 2016/17. The...


Jun 19, 2017, 02:46 ET Nuevolution Presents Additional Positive Animal Results in Lupus From its BET Selective Program

Nuevolution AB (publ) (NUE.ST) will participate in the BIO International Convention to be held in San Diego, 19-22 June, and will present new data on ...


Jun 12, 2017, 06:21 ET Nuevolution to Present at Anglo-Nordic Medicinal Chemistry Symposium

Nuevolution AB (publ) (NUE.ST) today announced that Thomas Franch, Chief Scientific Officer, will be presenting at the first Anglo-Nordic Medicinal...


Feb 14, 2017, 06:07 ET Nuevolution Technology Progress: Nuevolution Scales its Compound Collection to 40 Trillion Using its Chemetics™ Drug Discovery Platform

Nuevolution AB (publ) (NUE.ST) today announced the successful production and validation of its new ultra-high complexity library of 40 trillion...